$NanoVibronix (NAOV.US)$ Up

$DiDi Global (Delisted) (DIDI.US)$
imo this is a good buy, the institutions that bought at 14 couldnt possibly sell off unless they really do make money from this stock. Buying in at 14-15 now is such a discount for such much growth and potential this company has. further more buying in now means almost buying close to the 14 the institutions bought 🙌🏻

$Ocugen (OCGN.US)$ This is why the spike. Moomoo cui, simi not seeing company news
https://www.google.com.sg/amp/s/m.businesstoday.in/lite/story/bharat-biotech-submits-covaxin-phase-iii-clinical-trial-data-to-dcgi/1/442155.html

$Clover Health (CLOV.US)$ 谢谢您

$Orphazyme (ORPH.US)$
“We are disheartened by the outcome of the FDA’s review, given the urgent need for a new therapeutic option for NPC, but we remain committed to working with the regulators, with the goal of delivering arimoclomol tofamilies managing this challenging disease,” said CEO Christophe Bourdon. He continued: “We will focus our efforts on pursuing the European regulatory approval, with CHMP opinion expected in Q4 2021 and potential Marketing Authorization in Q1 2022. We are assessing the potential path forward in the U.S. in partnership with the FDA. In the short-term, we will need to reduce our costs substantially and freeze all company efforts not related to clinical and regulatory activities to support approval for NPC.”...

$AMC Entertainment (AMC.US)$ what time will the show starts tomorrow? 🍿

$Orphazyme (ORPH.US)$ will this be another distraction from AMC?

$ContextLogic (WISH.US)$ Is there any hope?